Scientist Known for Research Linking GM Feed with Cancerous Growth in Rats Wins Defamation and Forgery Court Cases

Séralini, the scientist known for his research linking GM feed with cancerous tumor growth in rats, has been through hell and back with his research on GMOs, but now it seems things are looking a little better for him. The Parisian High Court has indicted Marc Fellous, former chairman of France’s Biomolecular Engineering Commission (BEC), for “forgery” and “the use of forgery,” in a libel trial that he lost to Prof Gilles-Eric Séralini.

This bogus commission, BEC, has authorized numerous GM crops for human consumption, essentially lying to the masses, and trying to hide scientific results suggesting that genetically modified food is carcinogenic and health-damaging in a number of ways.

The details of the case have not yet been publicly released, but a source close to the case told GMWatch that Fellous had used or copied the signature of a scientist without his agreement to argue that Séralini and his co-researchers were wrong in their reassessment of Monsanto studies.

Two court cases have now been won by Séralini’s team. [1]

The latest trial demonstrated that the original author of the fraud accusation, prior to Marianne magazine, was the American lobbyist Henry I. Miller in Forbes magazine. Interestingly, Miller also tried to discredit scientists who linked tobacco use with cancer and heart disease in the name of that industry. It seems the biotech industry could purchase his skills for a similar price.

The long-term toxicity study by Séralini’s team was republished after the journal Food and Chemical Toxicology retracted it under


[1] GMWatch

Articles by: Christina Sarich

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: p[email protected]